# PRESSURE BIOSCIENCES INC

PRESSURE BIOSCIENCES INC is a company headquartered in Canton, MA, United States.

## Company overview

- **Legal name:** PRESSURE BIOSCIENCES INC
- **Former names in filing history:** BOSTON BIOMEDICA INC (1996-10-25 to 2004-09-02)
- **Classification:** Company
- **Industry (SIC):** 3826 — Laboratory Analytical Instruments
- **Headquarters:** Canton, MA, United States
- **Incorporated in:** MA
- **Fiscal year end:** December 31
- **SEC CIK:** 0000830656

## About

PRESSURE BIOSCIENCES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000830656, and its reported industry is Laboratory Analytical Instruments. In 10-K filed on 2024-06-07, it reported annual revenue of USD 1,977,763; net income of USD -29,314,298; total assets of USD 1,049,676 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $2.0M (USD 1,977,763)
- **Net income:** -$29.3M (USD -29,314,298)
- **Total assets:** $1.0M (USD 1,049,676)
- **Cash and equivalents:** $81,279 (USD 81,279)
- **Operating cash flow:** -$3.2M (USD -3,186,010)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $1.7M (USD 1,729,343)
- **Net income:** -$16.1M (USD -16,076,678)
- **Total assets:** $2.0M (USD 2,009,541)
- **Cash and equivalents:** $3,865 (USD 3,865)
- **Operating cash flow:** -$4.5M (USD -4,478,041)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $2.0M (USD 2,002,365)
- **Net income:** -$20.2M (USD -20,153,486)
- **Total assets:** $2.8M (USD 2,832,461)
- **Cash and equivalents:** $132,311 (USD 132,311)
- **Operating cash flow:** -$4.9M (USD -4,868,573)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $1.2M (USD 1,220,591)
- **Net income:** -$16.0M (USD -16,005,543)
- **Total assets:** $2.3M (USD 2,302,779)
- **Cash and equivalents:** $18,540 (USD 18,540)
- **Operating cash flow:** -$4.9M (USD -4,883,194)

## Recent SEC filings

- Form 10-Q — filed 2025-02-07 — period 2024-06-30
- Form 10-Q — filed 2024-09-06 — period 2024-03-31
- Form 8-K — filed 2024-07-17 — period 2024-07-17
- Form 8-K — filed 2024-07-03 — period 2024-06-18
- Form 10-K — filed 2024-06-07 — period 2023-12-31
- Form 8-K — filed 2024-04-22 — period 2024-04-18
- Form DEF 14A — filed 2024-02-27 — period 2024-02-27
- Form 8-K — filed 2024-01-25 — period 2024-01-19
- Form 10-Q — filed 2023-11-20 — period 2023-09-30
- Form 8-K — filed 2023-10-24 — period 2023-10-18
- Form 10-Q — filed 2023-08-21 — period 2023-06-30
- Form 10-Q — filed 2023-05-15 — period 2023-03-31

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/pressure-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology